Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001
Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 15, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has scheduled an Investor Forum at the Congress of
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock
Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock PLAINSBORO, N.J., Aug 13, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has closed its public offering of 5,060,000 shares of common stock
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock;
Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 9, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has priced a public offering of 5,060,000 shares of common stock at
View HTML
Toggle Summary Integra LifeSciences Reports Record Second Quarter Net Income on 35% Growth in Product Sales
Integra LifeSciences Reports Record Second Quarter Net Income on 35 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 2, 2001-- Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $4.7 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART)
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook
Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook PLAINSBORO, N.J., Jul 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has rescheduled its conference call to
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock
Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock PLAINSBORO, N.J.--(BUSINESS WIRE)--July 20, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced that it had filed an amendment to its registration
View HTML
Toggle Summary Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves
Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) -- Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received
View HTML
Toggle Summary Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA
Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding
View HTML
Toggle Summary Integra LifeSciences to Present at the Goldman Sachs Healthcare Conference
Integra LifeSciences to Present at the Goldman Sachs Healthcare Conference PLAINSBORO, N.J., Jun 8, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Goldman Sachs 22nd Annual Healthcare Conference in Dana Point,
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Files Shelf Registration Statement
Integra LifeSciences Holdings Corporation Files Shelf Registration Statement PLAINSBORO, N.J.--(BUSINESS WIRE)--June 1, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange
View HTML
Toggle Summary Integra NeuroSciences' Littlejohns Honored in AACN 2001 Circle of Excellence
Integra NeuroSciences' Littlejohns Honored in AACN 2001 Circle of Excellence PLAINSBORO, N.J.--(BUSINESS WIRE)--May 25, 2001--Integra NeuroSciences today announced that Linda Littlejohns, Vice President of Clinical Development, was the recipient of a Circle of Excellence Award from the American
View HTML
Toggle Summary Integra LifeSciences Reports Record First Quarter Net Income and Revenues; Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $3.7 Million
Integra LifeSciences Reports Record First Quarter Net Income and Revenues; Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $3.7 Million PLAINSBORO, N.J.--(BUSINESS WIRE)--May 9, 2001--Led by strong growth in revenues, Integra LifeSciences Holdings Corporation (Nasdaq:IART)
View HTML